Successful therapy confirmed for newborns with the fatal metabolic disorder MoCD type A
4 months ago
13
ARTICLE AD BOX
Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions.